Keyphrases
Mechanical Thrombectomy
60%
Aneurysm
46%
Thrombectomy
32%
Stroke Thrombectomy
32%
Clinical Outcomes
30%
Medium Vessel Occlusion
29%
Modified Rankin Scale
24%
Acute Ischemic Stroke
19%
Intracranial Aneurysm
19%
Oxidative DNA Damage
18%
Large Vessel Occlusion
18%
Propensity Score Analysis
16%
Gene Expression
16%
Chronic Subdural Hematoma
15%
Combustion Smoke
14%
Flow Diverter
13%
Flow Diverters
13%
Neurointerventionalist
13%
Endovascular Thrombectomy
13%
Middle Meningeal Artery Embolization
13%
International multicenter Study
13%
Symptomatic Intracerebral Hemorrhage (sICH)
12%
Functional Outcome
12%
Systematic Meta-analysis
12%
Meta-analysis
12%
Tumor
12%
Rat Brain
11%
Thrombolysis in Cerebral Infarction
11%
Insulin-like
11%
Growth Factors
11%
Stroke Patients
11%
Neurocysticercosis
10%
Neurosurgery
10%
Neuroendoscopic
10%
Endovascular Treatment
10%
Intracranial Hemorrhage
9%
Acute Inhalation
9%
Decompression
9%
COVID-19 Pandemic
9%
Balloon Catheter
9%
Infectious Diseases Society of America
9%
American Society
9%
Clinical Practice Guidelines
9%
Tropical Medicine
9%
Unmyelinated
9%
Hygiene
9%
Mitochondrial DNA Damage
9%
Peptide YY
9%
Global Impact
9%
Embolization
9%
Woven EndoBridge Device
9%
General Anesthesia
9%
Smoke Inhalation
9%
Glioblastoma
9%
National Institutes of Health Stroke Scale (NIHSS)
8%
Gracilis
8%
Mitochondrial DNA
8%
90-day Mortality
8%
Occlusion
8%
Glycoside Hydrolase
8%
Excision
8%
Confidence Interval
8%
Flow Diversion
8%
Fasciculus
8%
Resection
8%
Aging
7%
Endovascular
7%
Hypoxia
7%
Intraventricular Tumor
7%
DNA Glycosylase
7%
Intra-arterial Infusion
7%
Radiographic Outcomes
7%
Posterior Circulation
7%
Endoscopic Third Ventriculostomy
7%
Successful Recanalization
7%
Axon
7%
Procedural
7%
Intravenous Thrombolysis
7%
Alberta Stroke Programme Early CT Score (ASPECTS)
7%
Isolated Fourth Ventricle
7%
Posterior Circulation Stroke
7%
DNA Repair
7%
Stent
7%
Subgroup Analysis
6%
Anterior Circulation
6%
Treatment Options
6%
Stent Retriever
6%
Propensity Score Matching
6%
Surpass Streamline
6%
National Institutes of Health
6%
Glioma Cells
6%
Genetic Changes
6%
5-hydroxymethylcytosine (5hmC)
6%
Glioma
6%
Neurothrombectomy
6%
Brain Cancer
6%
Epigenetic Modification
6%
Inflammation
6%
Primary Brain Tumor
6%
Onyx Embolization
6%
Medicine and Dentistry
Apoplexy
100%
Mechanical Thrombectomy
66%
Thrombectomy
66%
Aneurysm
60%
Brain Ischemia
37%
Blood Clot Lysis
29%
Embolization
27%
Large Vessel Occlusion
27%
Cerebral Hemorrhage
25%
Neoplasm
25%
Modified Rankin Scale
24%
Intracranial Aneurysm
21%
Brain Infarction
20%
Systematic Review
15%
Subdural Hematoma
15%
Meta-Analysis
15%
COVID-19
14%
Percutaneous Thrombectomy
14%
Infection
13%
Middle Meningeal Artery
13%
Arterial Embolization
13%
Surgery
13%
Recanalization
12%
Odds Ratio
12%
Stenting
11%
National Institutes of Health Stroke Scale
10%
Neurocysticercosis
10%
Injury
10%
Internal Carotid Artery
10%
Neck
9%
Bleeding
9%
Brain Cancer
9%
General Anesthesia
9%
Tropical Disease
9%
Angioplasty
9%
Evacuation
9%
Puncture
8%
Retreatment
8%
Glioblastoma
8%
Gene Expression
8%
Cell Proliferation
7%
Intraarterial Drug Administration
7%
Surgeon
7%
Middle Cerebral Artery
7%
Propensity Score Matching
7%
Third Ventriculostomy
7%
Retrospective Cohort Study
6%
Dural Arteriovenous Fistula
6%
Ganglioglioma
6%
Intracranial Tumor
6%
Ventricle of Heart
6%
Posterior Communicating Artery
6%
Glioma Cell
6%
5 Hydroxymethylcytosine
6%
Cell Survival
6%
Subarachnoid Hemorrhage
6%
Craniofacial Synostosis
6%
Peptide YY
6%
Arachnoid Cyst
6%
Arteriovenous Fistula
6%
Intention-to-Treat Analysis
6%
First Pass Effect
6%
Computer Assisted Tomography
6%
Antiplatelet
6%
Stenosis
6%
Microsurgery
6%
Anterior Cerebral Artery
5%
Spine Surgery
5%
Malignant Neoplasm
5%
Sequela
5%
Obstruction
5%
Stem Cell
5%
Biopsy Technique
5%
Atrial Fibrillation
5%
Hematoma
5%
Infarction
5%
Thrombosis
5%